Published in

Springer, Breast Cancer Research and Treatment, 3(169), p. 469-479, 2018

DOI: 10.1007/s10549-017-4658-x

Links

Tools

Export citation

Search in Google Scholar

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

Journal article published in 2018 by Wolfgang Janni ORCID, Emilio Alba, Thomas Bachelot, Sami Diab, Miguel Gil-Gil, Thaddeus J. Beck, Larisa Ryvo, Rafael Lopez ORCID, Michaela Tsai, Francisco J. Esteva, Pilar Zamora Auñón, Zdenek Kral, Patrick Ward ORCID, Paul Richards, Timothy J. Pluard and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO